OS Therapies Announces Positive Phase 2b Results for OST-HER2 in Preventing Recurrence of Lung Metastatic Osteosarcoma

OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, ...

January 17, 2025 | Friday | News
Solid Biosciences Advances Toward Transformative Genetic Medicines with Expanded Pipeline and New Clinical Milestones

Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines fo...

January 17, 2025 | Friday | News
Eurofins Viracor Launches Groundbreaking Quantitative PCR Assay for Chagas Disease Detection

 Eurofins Viracor, LLC a leading provider of specialty diagnostic testing, and part of the global network of Eurofins companies, is pleased to announc...

January 17, 2025 | Friday | News
Incyte and Syndax Announce FDA Approval of Niktimvo™ for Chronic GVHD Treatment

 Incyte (Nasdaq:INCY) and Syndax Pharmaceuticals (Nasdaq:SNDX) announced that the U.S. Food and Drug Administration (FDA) has approved Niktimvo™...

January 16, 2025 | Thursday | News
Innovent Biologics’ IBI343 Receives Breakthrough Therapy Designation for Advanced Pancreatic Cancer in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

January 16, 2025 | Thursday | News
Celltrion Unveils Innovative Drug Development Strategy at J.P. Morgan Healthcare Conference

Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company,  announced its innovative drug development strategy in the rigorous and cutti...

January 15, 2025 | Wednesday | News
Samsung Biologics CEO John Rim Highlights 2025 Growth Strategy at J.P. Morgan Healthcare Conference

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO),  announced its latest business achievements a...

January 15, 2025 | Wednesday | News
Telix Pharmaceuticals CEO to Present at 43rd Annual J.P. Morgan Healthcare Conference

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, wil...

January 15, 2025 | Wednesday | News
Acadia Pharmaceuticals Highlights Strong Growth and Pipeline Advancements at J.P. Morgan Healthcare Conference

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced multiple business updates and progress on the Company's CNS and rare disease drug candidates, which wi...

January 15, 2025 | Wednesday | News
P3 Health Partners to Present at 2024 J.P. Morgan Healthcare Conference

P3 Health Partners Inc. (“P3” or the “Company”) (NASDAQ: PIII), a patient-centered and physician-led population health management c...

January 15, 2025 | Wednesday | News
Sotera Health Reports 5% Growth in 2024 Revenue, Provides Business Update at J.P. Morgan Healthcare Conference

 Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-...

January 15, 2025 | Wednesday | News
Bio-Rad Launches Nuvia wPrime 2A Media for Scalable Biomolecule Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, announced the launch of ...

January 15, 2025 | Wednesday | News
NVIDIA's CEO Jensen Huang Highlights AI Advancements in Healthcare at J.P. Morgan Conference

AI is making inroads across the entire healthcare industry — from genomic research to drug discovery, clinical trial workflows and patient care. I...

January 15, 2025 | Wednesday | News
Acadia Pharmaceuticals Submits Marketing Authorization Application for Trofinetide in the EU for Rett Syndrome Treatment

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) announced that the company has submitted a Marketing Authorization Application (MAA) to the European M...

January 15, 2025 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close